Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
Positive ▪️Revenue increased 12% year-over-year to $14.1 million ▪️Margin improved to 50% from 38.8% in the previous year ▪️Achieved adjusted EBITDA of $2.0 million, compared to a loss of $1.7 million last year ▪️Reported net income of $1.3 million ▪️Total costs and operating expenses decreased by $2.4 million or 15.8% ▪️Cost of oncology services decreased by 8.0% ▪️Research and development expenses reduced by 47.9% ▪️General and administrative expenses decreased by 14.0% ▪️Net cash provided by operating activities was $311,000 ▪️Company has no debt
Negative ▪️Potential revenue and margin volatility expected in coming quarters
▪️Cash on hand decreased to $2.9 million from $3.6 million at the end of the previous quarter
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more